Literature DB >> 18511444

From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.

Ying Qian1, Eva Feldman, Subramanian Pennathur, Matthias Kretzler, Frank C Brosius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18511444      PMCID： PMC4239998          DOI： 10.2337/db08-0061

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  72 in total

1.  Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.

Authors:  F Y Chow; D J Nikolic-Paterson; E Ozols; R C Atkins; B J Rollin; G H Tesch
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

2.  Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.

Authors:  T Babazono; J Kapor-Drezgic; J A Dlugosz; C Whiteside
Journal:  Diabetes       Date:  1998-04       Impact factor: 9.461

3.  Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.

Authors:  Gregory Proctor; Tao Jiang; Mieko Iwahashi; Zhuowei Wang; Jinping Li; Moshe Levi
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

4.  Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse.

Authors:  W Huang; Y Gallois; N Bouby; P Bruneval; D Heudes; M F Belair; J H Krege; P Meneton; M Marre; O Smithies; F Alhenc-Gelas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

5.  Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors.

Authors:  Masao Kakoki; Catherine M Kizer; Xianwen Yi; Nobuyuki Takahashi; Hyung-Suk Kim; C Robert Bagnell; Cora-Jean S Edgell; Nobuyo Maeda; J Charles Jennette; Oliver Smithies
Journal:  J Clin Invest       Date:  2006-04-06       Impact factor: 14.808

6.  Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

Authors:  K Horie; T Miyata; K Maeda; S Miyata; S Sugiyama; H Sakai; C van Ypersole de Strihou; V M Monnier; J L Witztum; K Kurokawa
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

7.  Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

Authors:  Maja T Lindenmeyer; Matthias Kretzler; Anissa Boucherot; Silvia Berra; Yoshinari Yasuda; Anna Henger; Felix Eichinger; Stefanie Gaiser; Holger Schmid; Maria P Rastaldi; Robert W Schrier; Detlef Schlöndorff; Clemens D Cohen
Journal:  J Am Soc Nephrol       Date:  2007-05-02       Impact factor: 10.121

8.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Authors:  T Yamamoto; T Nakamura; N A Noble; E Ruoslahti; W A Border
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor.

Authors:  Masao Kakoki; Nobuyuki Takahashi; J Charles Jennette; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

10.  Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications.

Authors:  M Marre; P Bernadet; Y Gallois; F Savagner; T T Guyene; M Hallab; F Cambien; P Passa; F Alhenc-Gelas
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461
View more
  110 in total

Review 1.  Nuclear receptors in renal disease.

Authors:  Moshe Levi
Journal:  Biochim Biophys Acta       Date:  2011-04-14

Review 2.  Nuclear hormone receptors in diabetic nephropathy.

Authors:  Xiaoxin X Wang; Tao Jiang; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

3.  Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.

Authors:  Jorge E Toblli; Gabriel Cao; Jorge F Giani; Margarita Angerosa; Fernando P Dominici; Nestor F Gonzalez-Cadavid
Journal:  Kidney Blood Press Res       Date:  2010-11-11       Impact factor: 2.687

4.  In rat renal fibroblasts, mycophenolic acid inhibits proliferation and production of the chemokine CCL2, stimulated by tumour necrosis factor-alpha.

Authors:  Hong-Wei Chang; Vin-Cent Wu; Kwan-Dun Wu; Hong-Yu Huang; Bor-Shen Hsieh; Yung-Ming Chen
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 5.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

6.  Cathepsin D protects renal tubular cells from damage induced by high glucose independent of its enzymatic activity.

Authors:  Feng Du; Tian Wang; Si Li; Xin Meng; Hai-Yan Zhang; De-Tian Li; Zhen-Xian Du; Hua-Qin Wang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 7.  Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.

Authors:  M Meier; J Menne; H Haller
Journal:  Diabetologia       Date:  2009-02-24       Impact factor: 10.122

8.  Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.

Authors:  Jorge E Toblli; Monica G Ferrini; Gabriel Cao; Dolores Vernet; Margarita Angerosa; Nestor F Gonzalez-Cadavid
Journal:  Nephrol Dial Transplant       Date:  2009-03-17       Impact factor: 5.992

9.  The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.

Authors:  Xiaoxin X Wang; Tao Jiang; Yan Shen; Luciano Adorini; Mark Pruzanski; Frank J Gonzalez; Pnina Scherzer; Linda Lewis; Shinobu Miyazaki-Anzai; Moshe Levi
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

10.  Reduction of Stat3 activity attenuates HIV-induced kidney injury.

Authors:  Xiaobei Feng; Ting-Chi Lu; Peter Y Chuang; Wei Fang; Krishna Ratnam; Huabao Xiong; Xinshou Ouyang; Yuhong Shen; David E Levy; Deborah Hyink; Mary Klotman; Vivette D'Agati; Ravi Iyengar; Paul E Klotman; John C He
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.